A vaccine aimed at preventing malaria is currently going through extensive testing to reinvigorate the fight against the mosquito-borne disease in Indonesia. A joint National Research and Innovation Agency (BRIN) team said in its newest report that it had entered the Phase 2 clinical trial of the vaccine, during which it administered a three-dose immunization regime to volunteers.